FR2674754B1 - Composition medicamenteuse micronisee. - Google Patents

Composition medicamenteuse micronisee.

Info

Publication number
FR2674754B1
FR2674754B1 FR9204122A FR9204122A FR2674754B1 FR 2674754 B1 FR2674754 B1 FR 2674754B1 FR 9204122 A FR9204122 A FR 9204122A FR 9204122 A FR9204122 A FR 9204122A FR 2674754 B1 FR2674754 B1 FR 2674754B1
Authority
FR
France
Prior art keywords
drug composition
micronized drug
micronized
active ingredient
administered orally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9204122A
Other languages
English (en)
Other versions
FR2674754A1 (fr
Inventor
Sung J. Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biofor Ltd
Original Assignee
Biofor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofor Ltd filed Critical Biofor Ltd
Publication of FR2674754A1 publication Critical patent/FR2674754A1/fr
Application granted granted Critical
Publication of FR2674754B1 publication Critical patent/FR2674754B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Lubricants (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR9204122A 1991-04-05 1992-04-03 Composition medicamenteuse micronisee. Expired - Fee Related FR2674754B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/680,997 US5271944A (en) 1991-04-05 1991-04-05 Pharmacologically enhanced formulations

Publications (2)

Publication Number Publication Date
FR2674754A1 FR2674754A1 (fr) 1992-10-09
FR2674754B1 true FR2674754B1 (fr) 1994-01-14

Family

ID=24733350

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9204122A Expired - Fee Related FR2674754B1 (fr) 1991-04-05 1992-04-03 Composition medicamenteuse micronisee.

Country Status (16)

Country Link
US (1) US5271944A (fr)
EP (1) EP0599914B1 (fr)
AT (1) ATE155687T1 (fr)
AU (1) AU1876792A (fr)
CA (1) CA2052901C (fr)
CH (1) CH683824A5 (fr)
DE (1) DE69221150T2 (fr)
DK (1) DK0599914T3 (fr)
ES (1) ES2108130T3 (fr)
FR (1) FR2674754B1 (fr)
IE (1) IE74211B1 (fr)
IT (1) ITTO920303A1 (fr)
NZ (1) NZ242233A (fr)
PT (1) PT100329B (fr)
WO (1) WO1992017163A1 (fr)
ZA (1) ZA922482B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
EP0812195B1 (fr) * 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Composition pharmaceutique pour composes de piperidinoalcanol
NZ501248A (en) * 1997-08-26 2001-06-29 Aventis Pharma Inc Pharmaceutical composition for combination of piperidinoalkanol-decongestant
EP1475093B1 (fr) 2000-04-24 2006-09-06 Teva Pharmaceutical Industries Ltd. Zolpidem Hemitartrate micronisé
DE20122435U1 (de) * 2000-04-24 2005-10-06 Teva Pharmaceutical Industries Ltd. Mikronisiertes Zolpidem-Hemitartrat
EP2135611A1 (fr) 2001-03-01 2009-12-23 Hollis-Eden Pharmaceuticals Inc. Derivés de Pregn-5-en-20-yn-3,7,17-triol pour utilisation thérapeutique
US6861066B2 (en) 2002-03-11 2005-03-01 Health Plus International Inc. Method for the delivery of a biologically active agent
US20060280761A1 (en) * 2002-03-11 2006-12-14 Health Plus International, Inc. Nanofluidized B-12 composition and process for treating pernicious anemia
BE1015641A4 (fr) * 2003-05-26 2005-07-05 Mariani Jean Paul Micronisation 70.
CA2542499A1 (fr) * 2003-10-16 2005-04-28 Teva Pharmaceutical Industries Ltd. Preparation de candesartan cilexetil
PL1633364T3 (pl) * 2004-01-05 2008-07-31 Teva Pharma Sposób wytwarzania zasady sildenafilu i cytrynianu sildenafilu
EP1713795A2 (fr) * 2004-02-11 2006-10-25 Teva Pharmaceutical Industries Ltd. Polymorphes de candesartan cilexetil
EP2471536A1 (fr) 2004-09-29 2012-07-04 Harbor BioSciences, Inc. Analogues de steroides, procedes de caracterisation et traitements
PT2273994E (pt) 2008-04-03 2016-03-15 Neurmedix Inc Formas de estado sólido de um produto farmacêutico
TW201613888A (en) 2014-09-26 2016-04-16 Helsinn Healthcare Sa Crystalline forms of an NK-1 antagonist

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
DE3204126A1 (de) * 1982-02-06 1983-08-11 Bayer Ag, 5090 Leverkusen Pyrazoloxazine, -thiazine, -chinoline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US4912093A (en) * 1986-10-01 1990-03-27 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
DE3723327A1 (de) * 1987-07-15 1989-02-02 Hoechst Ag Substituierte thienoimidazol-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer, magenschutzmittel sowie als medikament gegen intestinale entzuendungen
US4892870A (en) * 1988-08-01 1990-01-09 Biofor, Ltd. Oxaza heterocycles and pharmaceutical compositions containing same

Also Published As

Publication number Publication date
ITTO920303A1 (it) 1992-10-05
NZ242233A (en) 1993-07-27
PT100329B (pt) 1999-06-30
CH683824A5 (de) 1994-05-31
IE921040A1 (en) 1992-10-07
US5271944A (en) 1993-12-21
EP0599914A1 (fr) 1994-06-08
PT100329A (pt) 1993-07-30
DE69221150T2 (de) 1998-02-26
EP0599914A4 (en) 1994-08-24
ES2108130T3 (es) 1997-12-16
ATE155687T1 (de) 1997-08-15
FR2674754A1 (fr) 1992-10-09
DK0599914T3 (da) 1998-03-02
IE74211B1 (en) 1997-07-16
AU1876792A (en) 1992-11-02
ZA922482B (en) 1992-12-30
CA2052901A1 (fr) 1992-10-06
CA2052901C (fr) 1997-12-23
DE69221150D1 (de) 1997-09-04
EP0599914B1 (fr) 1997-07-23
ITTO920303A0 (it) 1992-04-02
WO1992017163A1 (fr) 1992-10-15

Similar Documents

Publication Publication Date Title
SE8700499D0 (sv) Novel pharmacologically active compounds
FR2674754B1 (fr) Composition medicamenteuse micronisee.
DE3679722D1 (de) Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
CR6210A (es) Composiciones de celecoxib
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
LV10268A (lv) Terapeitiski aktivs benzimidazols un ta iegusanas panemiens
IT9019112A1 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
GB2021409A (en) Pharmaceutical composition
DK0524696T3 (da) Orale præparater indeholdende dapiprazol
ATE103890T1 (de) Neue acylaminosaeurederivate enthaltende arzneimittel und diaetetika.
AU4040195A (en) Topical composition containing penciclovir
DE69123190D1 (de) Hirudin enthaltende orale Arzneimittel
IT1187743B (it) Composizioni farmaceutiche a base di destrorfano per applicazione instranasale
ATE44461T1 (de) Analgetische zusammensetzungen.
SE8104675L (sv) Farmacevtisk komposition med antiflogistisk, antipyretisk och analgetisk verkan
DE68903713D1 (de) Dextrorphansalze enthaltende orale arzneimittel.
KR880012518A (ko) 나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물
KR930004460A (ko) 에이(a) 87689 화합물
DE3777411D1 (de) Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln.
CO4790092A1 (es) Granisetron para tratamiento de la diarrea
ES2135424T3 (es) Composicion oral a base de ibuprofeno.
KR830005856A (ko) 소염, 해열 및 진통제 조성물
KR960021046A (ko) 카페익산을 포함하는 b형 간염 치료제

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse